Importance Cases of cerebral venous sinus thrombosis in combination with
thrombocytopenia have recently been reported within 4 to 28 days of vaccination with the …

Background and purpose High mortality rates have been reported in patients with cerebral
venous sinus thrombosis (CVST) due to vaccine‐induced immune thrombotic …

Background A new syndrome of vaccine-induced immune thrombotic thrombocytopenia
(VITT) has emerged as a rare side-effect of vaccination against COVID-19. Cerebral venous …

Background and Objectives There is accumulating evidence supporting an association
between the thrombosis and thrombocytopenia syndrome (TTS) and adenovirus vector …

Importance The COVID-19 pandemic saw one of the fastest developments of vaccines in an
effort to combat an out-of-control pandemic. The 2 most common COVID-19 vaccine …

During a 2-week period, we have encountered five cases presenting with the combination of
cerebral venous thrombosis (CVT), intracerebral hemorrhage and thrombocytopenia. A …

Objective To assess the association of COVID-19 vaccines and non-COVID-19 vaccines
with cerebral venous sinus thrombosis (CVST). Materials and method We retrospectively …

Objective We aimed to estimate the incidence of cerebral sinus and venous thrombosis
(CVT) within 1 month from first dose administration and the frequency of vaccine‐induced …

Importance Cerebral venous sinus thrombosis (CVST) with thrombocytopenia, a rare and
serious condition, has been described in Europe following receipt of the ChAdOx1 nCoV-19 …

Discussion SARS-CoV-2 infection has been associated with hypercoagulability, with a high
incidence of venous thromboembolism including pulmonary embolism and deep vein …